These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 24746792)
1. FDG PET/MR for lymph node staging in head and neck cancer. Platzek I; Beuthien-Baumann B; Schneider M; Gudziol V; Kitzler HH; Maus J; Schramm G; Popp M; Laniado M; Kotzerke J; van den Hoff J Eur J Radiol; 2014 Jul; 83(7):1163-1168. PubMed ID: 24746792 [TBL] [Abstract][Full Text] [Related]
2. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma. Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897 [TBL] [Abstract][Full Text] [Related]
3. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer? Schaefferkoetter JD; Carlson ER; Heidel RE J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746 [TBL] [Abstract][Full Text] [Related]
4. Influence of partial volume correction in staging of head and neck squamous cell carcinoma using PET/CT. Fayad H; Le Pogam A; Lamare F; Fernandez P; Pradier O; Valette G; Visvikis D; Cheze Le Rest C Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):319-28. PubMed ID: 25265252 [TBL] [Abstract][Full Text] [Related]
5. 18F-FDG-PET/CT for the assessment of the contralateral neck in patients with head and neck squamous cell carcinoma. Kastrinidis N; Kuhn FP; Hany TF; Ahmad N; Huber GF; Haerle SK Laryngoscope; 2013 May; 123(5):1210-5. PubMed ID: 23426442 [TBL] [Abstract][Full Text] [Related]
6. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. Kyzas PA; Evangelou E; Denaxa-Kyza D; Ioannidis JP J Natl Cancer Inst; 2008 May; 100(10):712-20. PubMed ID: 18477804 [TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282 [TBL] [Abstract][Full Text] [Related]
9. 18F-fluorodeoxyglucose uptake level-based lymph node staging in oropharyngeal squamous cell cancer--role of molecular marker expression on diagnostic outcome. Sadick M; Weiss C; Piniol R; Frey S; Hoermann K; Schoenberg SO; Sadick H Oncol Res Treat; 2015; 38(1-2):16-22. PubMed ID: 25633529 [TBL] [Abstract][Full Text] [Related]
10. The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes. Carlson ER; Schaefferkoetter J; Townsend D; McCoy JM; Campbell PD; Long M J Oral Maxillofac Surg; 2013 Jan; 71(1):162-77. PubMed ID: 22742956 [TBL] [Abstract][Full Text] [Related]
11. Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer. Tan R; Yao SZ; Huang ZQ; Li J; Li X; Tan HH; Liu QW Asian Pac J Cancer Prev; 2014; 15(18):7719-24. PubMed ID: 25292052 [TBL] [Abstract][Full Text] [Related]
12. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Adams S; Baum RP; Stuckensen T; Bitter K; Hör G Eur J Nucl Med; 1998 Sep; 25(9):1255-60. PubMed ID: 9724374 [TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed? Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410 [TBL] [Abstract][Full Text] [Related]
14. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study. Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791 [TBL] [Abstract][Full Text] [Related]
16. Bae MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY J Cancer Res Clin Oncol; 2020 Jan; 146(1):237-244. PubMed ID: 31606761 [TBL] [Abstract][Full Text] [Related]
17. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer. Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401 [TBL] [Abstract][Full Text] [Related]
18. FDG PET/MR for the assessment of lymph node involvement in lymphoma: initial results and role of diffusion-weighted MR. Platzek I; Beuthien-Baumann B; Ordemann R; Maus J; Schramm G; Kitzler HH; Laniado M; Kotzerke J; van den Hoff J Acad Radiol; 2014 Oct; 21(10):1314-9. PubMed ID: 25086953 [TBL] [Abstract][Full Text] [Related]
19. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI. Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients. An YS; Lee DH; Yoon JK; Lee SJ; Kim TH; Kang DK; Kim KS; Jung YS; Yim H Nuklearmedizin; 2014; 53(3):89-94. PubMed ID: 24220324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]